BeOne Medicines (ONC) Operating Expenses (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Operating Expenses data on file, last reported at $1.1 billion in Q1 2026.

• On a quarterly basis, Operating Expenses rose 16.48% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $4.4 billion, a 14.2% increase from a year earlier, with the FY2025 full-year figure at $4.2 billion, up 11.71% from the prior year.
• Operating Expenses for Q1 2026 stood at $1.1 billion, down from $1.2 billion in the prior quarter.
• Over the last five years, Operating Expenses for ONC reached as high as $1.2 billion in Q4 2025 and fell as low as $562.2 million in Q4 2022.
• Historically, Operating Expenses has averaged $900.8 million across 5 years, with a median of $898.2 million in 2024.
• Across the five-year window, Operating Expenses soared 148.77% in 2022 and declined 1.69% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $562.2 million in 2022, then soared by 62.27% to $912.4 million in 2023, then increased by 14.72% to $1.0 billion in 2024, then rose by 11.85% to $1.2 billion in 2025, then declined by 6.35% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.